Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2026 (TTM): -€0.31 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are €0.96 Billion. In 2025 the company made an earning of €0.24 Billion, an increase over its 2024 earnings that were of -€78.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2026

Annual earnings

Year	Earnings	Change
2026 (TTM)	-€0.31 Billion	-227.75%
2025	€0.24 B	-407.51%
2024	-€78.39 Million	-61.56%
2023	-€0.21 Billion	-7.43%
2022	-€0.23 Billion	34.42%
2021	-€0.17 Billion	-0.55%
2020	-€0.17 Billion	67.88%
2019	-€98.18 Million	7.55%
2018	-€91.28 Million	53.92%
2017	-€59.31 Million	19.29%
2016	-€49.72 Million	28.19%
2015	-€38.79 Million	-4.8%
2014	-€40.74 Million	50.09%
2013	-€27.15 Million	-23.29%
2012	-€35.39 Million	-26.19%
2011	-€47.94 Million	54.78%
2010	-€30.98 Million	150.1%
2009	-€12.39 Million	-49.43%
2008	-€24.49 Million	14.07%
2007	-€21.47 Million	-49.31%
2006	-€42.36 Million	72.87%
2005	-€24.5 Million	22.08%
2004	-€20.07 Million	75.3%
2003	-€11.45 Million	-25.36%
2002	-€15.34 Million	225.05%
2001	-€4.72 Million	-56.6%
2000	-€10.88 Million	50.63%
1999	-€7.22 Million	38.05%
1998	-€5.23 Million	-52.46%
1997	-€11 Million	58.44%
1996	-€6.95 Million	-14.44%
1995	-€8.12 Million	28.57%
1994	-€6.32 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Gilead Sciences GILD	-€2.29 Billion	614.06%	🇺🇸 USA
GSK plc GSK	€6.44 B	-2,116.87%	🇬🇧 UK
Sarepta Therapeutics SRPT	-€0.12 Billion	-63.09%	🇺🇸 USA
Repligen RGEN	€27.65 M	-108.65%	🇺🇸 USA
Novavax NVAX	-€0.21 Billion	-37.02%	🇺🇸 USA
Celldex Therapeutics CLDX	-€0.3 Billion	-8.15%	🇺🇸 USA
NanoViricides NNVC	-€7.41 Million	-97.68%	🇺🇸 USA
Cel-Sci CVM	-€20.07 Million	-93.72%	🇺🇸 USA
Emergent BioSolutions EBS	-€0.18 Billion	-45.14%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions